Vitamin C and Cancer

From eNewsletter 6/24/2026

DID YOU KNOW that a brief, intense workout may do more than boost fitness? It can help fight cancer.

According to a study from International Journal of Cancer, just 10 minutes of hard exercise releases molecules into the bloodstream that switch on DNA repair and shut down cancer growth signals. When these molecules were applied to bowel cancer cells, hundreds of cancer-related genes changed activity. The discovery helps explain how exercise lowers cancer risk.

To read the rest of today's issue, please go to this page.

Collagen Shines in Latest Data

From eNewsletter 6/22/2026

DID YOU KNOW that a study from Frontiers in Nutrition provided evidence that four weeks of high-dose collagen peptide supplementation favorably modulates bone formation and inflammatory signaling in premenopausal women?

Collagen intake increased P1NP (blood marker for bone formation) without altering CTX (bone marker for bone breakdown), suggesting a formation-driven response, and was accompanied by stabilization of the sRANKL/OPG ratio and a reduction in circulating IL-6 (an inflammatory marker).

To read the rest of this study, please go to this page.

Steve - I love this study because they used two tests I commonly recommend to clients beyond just a DEXA scan: P1NP and CTX.

Best Type of Exercise

From eNewsletter 6/17/2026

DID YOU KNOW that there is a new name for polycystic ovarian syndrome (PCOS), according to a study from The Lancet? It is now called polyendocrine metabolic ovarian syndrome (PMOS).

According to the authors, the term PCOS is inaccurate, implying pathological ovarian cysts, obscuring diverse endocrine and metabolic features, and contributing to delayed diagnosis, fragmented care, and stigma, while curtailing research and policy framing.

Building on an international mandate for change, the authors outlined an unprecedented, rigorous, multistep global consensus process for the name change. Funding and governance were established with engagement of 56 leading academic, clinical, and patient organizations.

Using global surveys (with responses from 14 360 people with PCOS and multidisciplinary health professionals from all world regions), modified Delphi methods, nominal group technique workshops, and marketing and implementation analyses, they identified principles prioritizing scientific accuracy, clarity, stigma avoidance, cultural appropriateness, and implementation feasibility. An accurate new name was prioritized over retaining the PCOS acronym or a generic name.

To read the rest of today's issue, please go to this page.